| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1027595137 |
| P356 | DOI | 10.2165/00019053-200624080-00003 |
| P698 | PubMed publication ID | 16898846 |
| P2093 | author name string | Stephen Joel Coons | |
| Isabelle Duprat-Lomon | |||
| Maria Kubin | |||
| Diane J Wild | |||
| Darren J Clayson | |||
| Paul Quarterman | |||
| P2860 | cites work | Quality of life and risk perception among predominantly heterosexual, minority individuals with HIV/AIDS. | Q53472183 |
| HIV-seropositive results, health-related quality of life, and social support: a 24-week prospective study in Thailand. | Q53485576 | ||
| AIDS — The First 20 Years | Q22250904 | ||
| The Health Utilities Index (HUI): concepts, measurement properties and applications | Q24616711 | ||
| Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease | Q24794133 | ||
| Optimal clinical trial designs for immune-based therapies in persistent viral infections | Q24799820 | ||
| Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project | Q24800272 | ||
| The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
| Health-related quality-of-life evaluation in HIV-infected patients. A review of the literature | Q33569691 | ||
| A comparative review of generic quality-of-life instruments | Q33881659 | ||
| Health-related quality-of-life measurements in HIV/AIDS care | Q34025800 | ||
| EQ-5D: a measure of health status from the EuroQol Group | Q34086093 | ||
| The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies | Q34086097 | ||
| Psychometric evaluation of four HIV disease-specific quality-of-life instruments | Q34247270 | ||
| Lipodystrophy syndrome in patients with HIV infection: quality of life issues | Q34248411 | ||
| The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
| US valuation of the EQ-5D health states: development and testing of the D1 valuation model. | Q34396720 | ||
| The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center | Q34442249 | ||
| Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients. | Q34443739 | ||
| Development and validation of a self-completed HIV symptom index. | Q34466580 | ||
| The survival benefits of AIDS treatment in the United States | Q34533291 | ||
| Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens | Q34647483 | ||
| The association of health-related quality of life with survival among persons with HIV infection in the United States | Q34722605 | ||
| An overview of generic health-related quality of life measures for HIV research | Q35221507 | ||
| Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS). | Q36885973 | ||
| Quality of life as a function of HIV classification | Q39258114 | ||
| Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument | Q39431801 | ||
| Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals | Q39454346 | ||
| Modeling valuations for EuroQol health states | Q39513119 | ||
| Quality of life in women with symptomatic HIV/AIDS. | Q39518519 | ||
| Impact of psychiatric conditions on health-related quality of life in persons with HIV infection | Q39528799 | ||
| A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy. | Q39532037 | ||
| Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey. | Q51981418 | ||
| Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. | Q51984235 | ||
| Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). | Q51995010 | ||
| Use of the MQoL-HIV with asymptomatic HIV-positive patients. | Q51999489 | ||
| Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20. | Q52009458 | ||
| The Functional Status Questionnaire: reliability and validity when used in primary care. | Q52078868 | ||
| Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group | Q52419438 | ||
| The health-related quality of life in a Swedish sample of HIV-infected persons. | Q52541767 | ||
| Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1. | Q52553799 | ||
| Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International Quality of Life Assessment. | Q53350383 | ||
| Measuring health related quality of life among women living with HIV. | Q53491054 | ||
| Gender differences in perceived health-related quality of life among patients with HIV infection. | Q53499653 | ||
| Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients. | Q53511425 | ||
| Economic methods for measuring the quality of life associated with HIV infection. | Q53538576 | ||
| Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users. | Q53612512 | ||
| Quality of life in HIV disease as measured by the McGill quality of life questionnaire. | Q53616525 | ||
| A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. | Q53622586 | ||
| The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison. | Q53625151 | ||
| An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial. | Q53858744 | ||
| Cardiovascular disease in HIV-positive patients. | Q53861364 | ||
| Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study | Q57313900 | ||
| Quality of life assessment in HIV-positive persons: Application and validation of the WHOQOL-HIV, Italian version | Q58106455 | ||
| Predictors of Changes in Health-Related Quality of Life Among Men with HIV Infection in the HAART Era | Q59603546 | ||
| Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires | Q59780754 | ||
| Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collabor | Q70835629 | ||
| Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 | Q71026049 | ||
| Describing the health-related quality of life impact of HIV infection: findings from a study using the HIV Overview of Problems--Evaluation System (HOPES) | Q72223030 | ||
| Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group | Q72395008 | ||
| Derivation and properties of a brief health status assessment instrument for use in HIV disease | Q72553132 | ||
| Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team | Q72852761 | ||
| The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis | Q72894201 | ||
| Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha | Q72894242 | ||
| The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV | Q73117394 | ||
| Impact of combination therapy for HIV infection on inpatient census | Q73351138 | ||
| Functional Status and Overall Quality of Life in a Multiethnic HIV-Positive Population | Q73370329 | ||
| Measuring quality of life in early HIV disease: the modular approach | Q73788548 | ||
| Measuring quality of life from the point of view of HIV-positive subjects: the HIV-QL31 | Q73788557 | ||
| Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study | Q73977354 | ||
| Progress and problems in the fight against AIDS | Q74357692 | ||
| A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group | Q77198688 | ||
| Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS | Q80928397 | ||
| General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G) | Q81685445 | ||
| Validation of a specific questionnaire on psychological and social repercussions of the lipodystrophy syndrome in HIV-infected patients | Q83835083 | ||
| Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection | Q39566862 | ||
| Assessing a conceptual framework of health-related quality of life in a HIV/AIDS population | Q39724565 | ||
| Abuse, HIV status and health-related quality of life among a sample of HIV positive and HIV negative low income women | Q39724570 | ||
| Predictors of quality of life in HIV-infected rural women: psychometric test of the chronic illness quality of life ladder | Q40322509 | ||
| The estimation of a preference-based measure of health from the SF-36. | Q40647897 | ||
| Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques | Q40682181 | ||
| Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument | Q40738318 | ||
| The AIDS epidemic--considerations for the 21st century | Q40795784 | ||
| Measuring health-related quality of life among patients infected with human immunodeficiency virus | Q40870886 | ||
| Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). | Q40884697 | ||
| The influence of health-related quality of life and social characteristics on hospital use by patients with AIDS in the Boston Health Study. | Q40926250 | ||
| Access to Medical Care and Health-Related Quality of Life for Low-Income Persons with Symptomatic Human Immunodeficiency Virus | Q40980982 | ||
| Quality of life assessment and HIV infection: a review | Q41180434 | ||
| Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. | Q41612046 | ||
| Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study | Q41752353 | ||
| Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial | Q42162746 | ||
| A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: development, reliability, and validity | Q43599290 | ||
| Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease | Q43758650 | ||
| Health-related quality of life in persons with acquired immune deficiency syndrome. | Q43962410 | ||
| Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. | Q44083709 | ||
| Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone | Q44197634 | ||
| Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. | Q44326376 | ||
| Predictors of quality of life in AIDS patients | Q44387801 | ||
| Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex | Q44394167 | ||
| Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. | Q44814046 | ||
| Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument | Q45297743 | ||
| Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. | Q45730351 | ||
| The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus | Q45738782 | ||
| Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group | Q45783333 | ||
| Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. | Q45786181 | ||
| Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases | Q45853622 | ||
| Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. | Q45969416 | ||
| A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity. | Q46043360 | ||
| A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection | Q46058916 | ||
| The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease | Q46118002 | ||
| Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life | Q46166822 | ||
| Validation of the quality of life scale: living with HIV. | Q46221409 | ||
| Gender differences in health-related quality of life in patients with HIV/AIDS. | Q46488984 | ||
| WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: results from the field test | Q47318421 | ||
| Preliminary development of the World Health Organsiation's Quality of Life HIV instrument (WHOQOL-HIV): analysis of the pilot version | Q47382720 | ||
| Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons | Q47405408 | ||
| Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort | Q48604431 | ||
| Health related quality of life among persons with HIV after the use of protease inhibitors. | Q50673052 | ||
| Improvements in health-related quality of life following a group intervention for coping with AIDS-bereavement among HIV-infected men and women. | Q50961467 | ||
| Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. | Q50974670 | ||
| Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. | Q51076833 | ||
| Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES) | Q51147411 | ||
| Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. | Q51836910 | ||
| Nature and correlates of SF-12 physical and mental quality of life components among low-income HIV adults using an HIV service center. | Q51927721 | ||
| Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. | Q51931076 | ||
| The Impact of Apathy and Depression on Quality of Life in Patients Infected with HIV | Q51949000 | ||
| Health-related quality of life after 1 year of highly active antiretroviral therapy. | Q51951263 | ||
| Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV-infected patients in Singapore. | Q51953896 | ||
| Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. | Q51956021 | ||
| Health-related quality of life and virologic outcomes in an HIV clinic. | Q51967153 | ||
| Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection. | Q51980628 | ||
| P433 | issue | 8 | |
| P921 | main subject | HIV/AIDS | Q12199 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 751-765 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | PharmacoEconomics | Q7180778 |
| P1476 | title | A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials | |
| P478 | volume | 24 |
| Q38956665 | A Review of HIV-Specific Patient-Reported Outcome Measures |
| Q37556870 | A comparison of quality of life between HIV positive and negative diamond miners in South Africa |
| Q34573642 | A comparison of the MOS-HIV and SF-12v2 for measuring health-related quality of life of men and women living with HIV/AIDS |
| Q36336208 | A mixed methods approach to adapting and evaluating the functional assessment of HIV infection (FAHI), Swahili version, for use with low literacy populations |
| Q37411769 | Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso |
| Q41497086 | Association among oral symptoms, oral health-related quality of life, and health-related quality of life in a sample of adults living with HIV/AIDS in Malaysia |
| Q39929987 | Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial |
| Q48649781 | Depression and reasons for living among AIDS patients: protecting quality of life when the end is in sight |
| Q39988904 | Determinants of health-related quality of life in adults living with HIV in Vietnam |
| Q38018282 | Development of a new instrument for the assessment of psychological predictors of well-being and quality of life in people with HIV or AIDS. |
| Q37693308 | Does duration on antiretroviral therapy determine health-related quality of life in people living with HIV? A cross-sectional study in a regional referral hospital in Kenya |
| Q45041241 | Effect of Lipodystrophy on the Quality of Life among People Living with HIV (PLHIV) on Highly Active Antiretroviral Therapy. |
| Q47098172 | Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women. |
| Q35633128 | EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care |
| Q37400027 | Evaluation of the methodological quality of systematic reviews of health status measurement instruments |
| Q53798976 | Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists. |
| Q35651599 | Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study |
| Q49070887 | Factors influencing the quality of life in patients with HIV in Malaysia |
| Q40301707 | Field Psychometric Testing of the Instrument for Assessment of Psychological Predictors of Well-Being and Quality of Life in People with HIV or AIDS. |
| Q35780707 | Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US. |
| Q45773759 | Health related quality of life of HIV/AIDS patients on highly active anti-retroviral therapy at a university referral hospital in Ethiopia |
| Q38781773 | Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia. |
| Q35664740 | Health-related quality of life assessment after antiretroviral therapy: a review of the literature |
| Q33298844 | Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study |
| Q34114741 | How do existing HIV-specific instruments measure up? Evaluating the ability of instruments to describe disability experienced by adults living with HIV. |
| Q34487057 | Improving HIV outcomes in resource-limited countries: the importance of quality indicators |
| Q28081861 | Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis |
| Q64099491 | Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D |
| Q47094565 | Measuring quality of life among people living with HIV: a systematic review of reviews |
| Q38050114 | More than 20 years of research into the quality of life of people with HIV and AIDS--a descriptive review of study characteristics and methodological approaches of published empirical studies |
| Q37457987 | Pain is independently associated with impaired physical function in HIV-infected patients |
| Q42273804 | Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE]. |
| Q84320630 | Psychometric evaluation of the functional assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials |
| Q55079226 | Psychometric properties of the Korean version of the medical outcomes study HIV health survey: results from a multicenter survey in Korea. |
| Q39244056 | Psychosocial and Service Use Correlates of Health-Related Quality of Life Among a Vulnerable Population Living with HIV/AIDS. |
| Q39837593 | Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru. |
| Q49297474 | Quality of life among South African patients receiving antiretroviral therapy in the Western Cape Province |
| Q37196385 | Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme |
| Q35066375 | Quality of life in HIV/AIDS |
| Q36521187 | Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients |
| Q36559494 | Randomised controlled pilot study to assess the feasibility of a Mediterranean Portfolio dietary intervention for cardiovascular risk reduction in HIV dyslipidaemia: a study protocol. |
| Q46544839 | Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression |
| Q36339142 | Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders |
| Q38089967 | Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies |
| Q43236765 | Satisfactory cross-cultural validity of the ACTG symptom distress module in HIV-1-infected antiretroviral-naive patients |
| Q39582791 | Sensibility assessment of the HIV Disability Questionnaire. |
| Q46471920 | Short-term physical and emotional health outcomes of public sector ART in the Free State province of South Africa |
| Q46762271 | Spirituality/Religion and Quality of Life in Patients with HIV/AIDS. |
| Q43136745 | Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients |
| Q39236648 | Technology-Mediated Interventions and Quality of Life for Persons Living with HIV/AIDS. A Systematic Review. |
| Q38829492 | The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis. |
| Q56785853 | The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS |
| Q40509615 | The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá. |
| Q35075546 | The quality of life of men who have sex with men in China: reliability and validity testing of the SF-36 questionnaire |
| Q37196673 | The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov |
| Q40492630 | Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment. |
| Q84965714 | Validation of the medical outcomes study HIV (MOS-HIV) health survey among HIV-infected patients in Taiwan |
| Q35068416 | What determines health-related quality of life among people living with HIV: an updated review of the literature |
| Q48452953 | What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors |
| Q39145817 | Which dimensions of disability does the HIV Disability Questionnaire (HDQ) measure? A factor analysis |
Search more.